CClinicalTrials.gg
CompletedNCT05227729Updated Apr 25, 2024

Descending Aorta Blood Flow to Guide Fluid Therapy During Surgery

An observational study in Hemodynamic Instability, sponsored by Sykehuset Telemark. Completed at 1 site in Norway. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-25.

Sponsored by Sykehuset Telemark · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
30
Ages
18 Years and older
Sex
All
01

Study summary

The investigators will perform a clinical observational study of patients undergoing abdominal surgery. The study will be performed at Sykehuset Telemark, Skien. The aims of the study are to compare suprasternal and transoesophageal Doppler (reference method) to measure blood flow in the proximal descending aorta and to explore the variability of hemodynamic variables during surgery.

Read the detailed description

Background and aim: The best validated method to estimate cardiac output with ultrasound requires measuring the Doppler velocity time integral (VTI) in the left ventricular outflow tract measured from the apical (lateral chest) window/ projection. However, this projection is often out of reach for anaesthesiologists during many surgical procedures (e.g. abdominal surgery) due to draping, and is often difficult to perform if the patient cannot be placed in the left lateral decubitus position. Alternatively, VTI in the proximal descending aorta may be measured via the suprasternal view, which is one of the standard projections in transthoracic echocardiography. This view is often available for anaesthesiologists during surgery on a patient in supine position. Assuming that changes in cardiac output are associated with changes in VTI in proximal descending aorta, this may provide the anaesthesiologist with a non-invasive measure of the response to a fluid challenge. The first aim of this study is to evaluate the ability of suprasternal Doppler to measure blood flow in the proximal descending aorta, and its agreement with the reference method oesophageal Doppler, during ongoing abdominal surgery.

Fluid challenges are typically given when stroke volume is reduced by 10-15%, which is considered a significant reduction. This is however dependent on the precision of the measurements, which is estimated during hemodynamic stability. During surgery, on the other hand, the variability may be larger, leading to erroneously concluding that stroke volume is reduced due to volume loss, when in fact this may be due to other stimuli related to surgery (mechanical, e.g. compression of large veins or the thoracic cavity, or stimuli affecting the autonomic nervous system, e.g. pain). The proportion of potentially falsely measured reduction may be calculated by performing repeated measurements during ongoing surgery. Thus, an other aim with this study is to explore the variability of measurements of stroke volume during surgery.

Study design: Clinical observational study.

Data collection: 30 patients scheduled to undergo laparoscopic or open abdominal surgical procedures (gastrointestinal or gynecological) of at least 1.5 hrs estimated duration. The patients should be of American Society of Anesthesiologists physical status 1-3 and have no contraindications to the use of oesophageal ultrasound. Hemodynamic data will be downloaded to a PC continuously from the clinical monitoring equipment (Philips Intellivue) using the VSCapture software (https://github.com/xeonfusion/VSCaptureMP) in VisualStudio (Microsoft). "Landmarks" in the procedure (e.g. surgical incision, manipulation in the surgical field and hemorrhage) will be recorded manually to relate the hemodynamic data to the different steps in the procedure. Blood flow velocity in the descending aorta will be measured using ultrasound machines in ordinary clinical use (GE Venue R 2.5; GE Healthcare). The Doppler recordings will be analyzed using commercially available software (EchoPAC; General Electric) after blinding.

Data analyzes:

  • Considerations regarding sample size for agreement analyzes: The investigators will focus on within-subject variability, and the main outcome will be the corresponding within-subject limits of agreement. If both methods have a precision of 2.9%, limits of agreement will be 8.3%. Given 18 measurements per subject (one measurement every 5 min over 1.5 hrs), 25 subjects will give an 80% power for an upper confidence interval of the limits of agreement of 18%. By including 30 patients, the investigators allow for some unsuccessful measurements due to e.g. poor echogenicity.
  • Considerations regarding sample size for variability analyzes: Given that the SD of oesophageal Doppler is 2.9%, the precision is 2.9%×1.96=5.7%. The probability of each evaluation of showing a false reduction is 0.8%. If surgery lasts 1.5 hrs with one evaluation every 5 min, the probability of at least one false reduction is 12%. If the precision is reduced with a doubled SD, the probability of at least one false reduction is 88%. Assuming a true SD of 2.9%; studying 25 subjects gives a power of 0.8 to detect a SD \<3.0%.
02

Conditions studied

  • Hemodynamic Instability

Keywords

  • Hemodynamics
  • Blood Circulation
  • Aorta, Thoracic
03

In context

Lead sponsor

Sykehuset Telemark is the lead sponsor of 32 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients that plan to undergo abdominal surgery (gastrointestinal or gynecological) at Telemark hospital, Skien, Norway.

Inclusion criteria

  • Patients scheduled to undergo laparoscopic or open abdominal surgical procedures (gastrointestinal or gynecological) of at least 1.5 h estimated duration.
  • The patients should be of American Society of Anesthesiologists physical status 1-3

Exclusion criteria

Exclusion Criteria:

  • Pathology in the larynx, oesophagus or stomach
  • Former surgery in larynx, oesophagus or stomach
  • Thoracic aortic aneurysm.
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
30 participants (actual)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Patients undergoing abdominal surgery

    Inclusion criteria: \> 18 years old, American Society of Anesthesiologists physical status 1-3, abdominal surgery of \> 1,5 hrs estimated duration, no contraindications to the use of oesophageal ultrasound.

    Diagnostic Test: Measurement of blood flow in descending aorta by suprasternal ultrasound Doppler technique · Diagnostic Test: Measurement of blood flow in descending aorta by transoesophageal ultrasound Doppler technique

Interventions

  • Diagnostic testMeasurement of blood flow in descending aorta by suprasternal ultrasound Doppler technique

    While study subjects are in general anesthesia the investigator will perform repeated measurements every 5 min.

  • Diagnostic testMeasurement of blood flow in descending aorta by transoesophageal ultrasound Doppler technique

    While study subjects are in general anesthesia the investigator will perform repeated measurements every 5 min.

06

What researchers measure

Primary outcomes

  1. Change in blood flow velocity in descending aorta

    Suprasternal Doppler

    Time frame: During surgery, every 5 minutes. At least over a time period of 1,5 hours

  2. Change in blood flow velocity in descending aorta

    Transoesophageal Doppler

    Time frame: During surgery, every 5 minutes. At least over a time period of 1,5 hours

  3. Change in stroke volume

    Calculated from the measurements by transoesophageal Doppler

    Time frame: During surgery, every 5 minutes. At least over a time period of 1,5 hours

Secondary outcomes

  1. Change in heart rate

    Measured in beats per minute, collected from standard monitoring device during surgery

    Time frame: During surgery, every 5 minutes. At least over a time period of 1,5 hours

  2. Change in systemic vascular resistance

    Measured in dynes/second/cm\^5. Calculated from the measurements by transoesophageal Doppler and standard monitoring device (mean arterial pressure)

    Time frame: During surgery, every 5 minutes. At least over a time period of 1,5 hours

  3. Change in blood pressure

    Measured in mmHg, collected from standard monitoring device during surgery

    Time frame: During surgery, every 5 minutes. At least over a time period of 1,5 hours

07

Study locations

1 site
  • Telemark Hospital Trust
    Skien, Vestfold Og Telemark 3710, Norway
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05227729
Lead sponsor
Sykehuset Telemark
Collaborators
Oslo University Hospital, University of Oslo
Responsible party
Torkjell Nostdahl (Principal investigator, Sykehuset Telemark) — Principal investigator
First posted
Feb 7, 2022
Start date
Oct 18, 2022
Primary completion
Jan 29, 2024
Completion
Jan 29, 2024
Last update
Apr 25, 2024

Study contacts

Torkjell Nøstdahl, MD, PhD
principal investigator · Telemark Hospital Trust

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion